FMP
NASDAQ
3.51 USD
-0.18 (-5.13%)
Dr. Amit Kumar Ph.D.
Healthcare
Biotechnology
https://www.anixa.com
NASDAQ
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is als...
0000715446
US03528H1095
03528H109
3150 Almaden Expressway
408 708 9808
US
4
Oct 7, 1983
0000715446
NASDAQ
Biotechnology
Healthcare
03528H109
US03528H1095
US
3.51
0.86
154.5k
111.97M
-
2.75-6.45
0.01
-
-
-
-
-10.32
-
https://www.anixa.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.